FIELD: medicine.
SUBSTANCE: invention concerns virology and biotechnology area. The way provides introduction of the vaccine chosen from a group, consisting (a) from modified live vaccine BVDV of type 1, (b) from modified live vaccine BVDV of type 2, and (c) simultaneously from modified live vaccine BVDV of type 1 and modified live vaccine BVDV of type 2 to an animal. The invention is effective for prevention or depression of an infection of the spermaries caused by infection BVDV of type 1 and 2. The invention can be used in veterinary science and animal industries.
EFFECT: prevention or depression of an infection of the spermaries caused by infection BVDV.
20 cl, 1 dwg, 4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BOVINE VIRAL DIARRHOEA VIRUS TYPE 1B VACCINE COMPOSITIONS AND METHODS FOR PRODUCTION AND USE THEREOF | 2011 |
|
RU2595873C2 |
| MUCROFLUIDIC OIL-IN-WATER EMULSION AND VACCINE COMPOSITIONS | 2004 |
|
RU2541809C2 |
| MUTANT VIRUS OF BULL DIARRHEA | 2006 |
|
RU2394594C2 |
| CATTLE DIARRHEA VIRUS WITH MODIFIED E PROTEIN | 2009 |
|
RU2524426C2 |
| VACCINE FORMULA AGAINST BOVINE RESPIRATORY PATHOLOGIES | 2002 |
|
RU2305560C2 |
| NEW ADJUVANT COMPOSITIONS | 2009 |
|
RU2510280C2 |
| BVDV VACCINE | 2011 |
|
RU2578943C2 |
| MICROFLUIDISED OIL-IN-WATER EMULSIONS AND VACCINE COMPOSITIONS | 2005 |
|
RU2347586C2 |
| ENHANCED IMMUNE RESPONSE IN BOVINE SPECIES | 2011 |
|
RU2606855C2 |
| LIQUID STABLE VACCINES CONTAINING BOVINE VIRUS | 2014 |
|
RU2723935C2 |
